MedTrace Logo

Fixed Dose Heparin Study

NCT00182403 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 866

Last updated 2017-06-07

No results posted yet for this study

Summary

FIDO was a multicentred randomized, open-label trial that compared fixed-dose UFH with fixed-dose LMWH for initial treatment of VTE. Patients were followed for 3 months during which they received warfarin (target INR 2.0-3.0).

Conditions

Interventions

DRUG

UFH 250 U/kg or LMWH 100 U/kg sc twice daily

Sponsors & Collaborators

Principal Investigators

  • Clive Kearon, MB Ph.D · Hamiton Health Sciences

  • Jim Julian, MMath · McMaster-Dept. of Clinical Epidemiology &Biostatistics

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1998-09-30
Completion
2004-05-31

Countries

  • Canada
  • New Zealand

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00182403 on ClinicalTrials.gov